MicrosoftEvidence: Medium50/100

Yseop Copilot Automates Medical Writing for Pharma Companies Using Microsoft Word

Yseop Copilot automates time-consuming regulatory writing tasks for pharmaceutical companies by producing first drafts of clinical study reports, clinical trial narratives, safety and efficacy summaries, investigator brochures, and informed consent forms. It integrates natively with Microsoft Word so medical writers can focus on scientific interpretation and higher-value work while generating compliant document drafts faster.

Organization
Eli Lilly
Industry
Pharma
Location
France
Published
June 2024

Reported outcomes

30-50%

authoring time reductionTime & speed

+50%productivity efficiency gain−99.9%patient narrative writing time14 daysdatabase lock to report acceleration

Strategic outcomes

Risk & complianceSupports FDA and EMA compliant document generationCost efficiencyFrees medical writers for complex scientific workRisk & complianceReduces risk of human error in data review

Catalog median for time & speed deployments: −50% across 312 reported metrics. Compare benchmarks →

Why do we believe this?Outcome claims, sources, and evidence checks

Normalized claim

Productivity efficiency gain: 50% increase

YseopJun 26, 2024Customer storyExplicit claimMedium evidence strength

"50% productivity efficiency gain"

Normalized claim

Authoring time reduction: 30-50% decrease

YseopJun 26, 2024Customer storyExplicit claimMedium evidence strength

"30-50% reduction in authoring time"

Normalized claim

Patient narrative writing time: 99.9% decrease

YseopJun 26, 2024Customer storyInferred claimMedium evidence strength

"It used to take us a minimum of 4 hours to write 1 patient narrative. Now, it takes 4 seconds"

Normalized claim

Database lock to report acceleration: 14 days decrease

YseopJun 26, 2024Customer storyExplicit claimMedium evidence strength

"2-week acceleration from DBL"

Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
Customer
Eli Lilly, Sanofi
Provider
Microsoft
Maturity
Unknown
Linked source
Yseop

No explicit deployment-stage evidence found.

Customer identity supportedSource describes one deploymentMaturity evidence evaluated

Primary read

Use case focus

Showing 3 of 3

  • 1Medical writing automation
  • 2Document automation
  • 3Content generation
Medical writers in pharmaceutical companies need to produce highly accurate regulatory documents quickly while meeting FDA and EMA compliance requirements and reducing repetitive administrative work.
  • Yseop Copilot is a neuro-symbolic AI platform that integrates natively with Microsoft Word.
  • It automates core reporting workflows by generating first drafts of clinical study reports, clinical trial narratives, summaries of clinical safety and efficacy, investigator brochures, informed consent forms, and related regulatory content.
  • The platform is used in controlled medical-writing workflows so human writers can focus on interpretation and validate the generated output.
  • The source reports a 50% productivity efficiency gain.
  • It claims 30-50% reduction in authoring time and a 2-week acceleration from database lock to report generation.
  • It also says patient narrative writing dropped from 4 hours to 4 seconds.
Architecture

Yseop Copilot is described as a neuro-symbolic AI platform that works natively in Microsoft Word and automates drafting of regulated medical documents for pharma teams.

Sources & evidence1
Evidence: Medium50/100Evidence strength
  • Customer explicitly identified
  • Primary source available
  • Quantified outcome available
  • Technical implementation details available
Type: Customer StoryPublished: Jun 26, 2024Publisher: YseopEvidence: PrimaryConfidence: High

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Was this useful?

Community

Comments

No published comments yet.